Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Neuroscience (ANRO) Other financing activities (2023 - 2025)

Alto Neuroscience has reported Other financing activities over the past 3 years, most recently at $127000.0 for Q1 2025.

  • Quarterly results put Other financing activities at $127000.0 for Q1 2025, down 97.26% from a year ago — trailing twelve months through Dec 2025 was $127000.0 (changed N/A YoY), and the annual figure for FY2025 was $127000.0, changed.
  • Other financing activities reached $127000.0 in Q1 2025 per ANRO's latest filing, up from -$4.6 million in the prior quarter.
  • Across five years, Other financing activities topped out at $4.6 million in Q1 2024 and bottomed at -$4.6 million in Q2 2024.
  • Median Other financing activities over the past 3 years was $140500.0 (2023), compared with a mean of $46833.3.
  • Peak annual rise in Other financing activities hit 2914.94% in 2024, while the deepest fall reached 2914.94% in 2024.
  • Over 3 years, Other financing activities stood at $154000.0 in 2023, then crashed by 3114.94% to -$4.6 million in 2024, then surged by 102.74% to $127000.0 in 2025.
  • Business Quant data shows Other financing activities for ANRO at $127000.0 in Q1 2025, -$4.6 million in Q2 2024, and $4.6 million in Q1 2024.